Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4057511

C=C(C)C(=O)OC(N)(N)CN.Cl

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TSHR P16473 3/20 0.38
THRB P10828 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27788303 0.80 ALDH1A1 (0.42) ALDH1A1TSHRTHRBTDP1
SCHEMBL29022549 0.80 ALDH1A1 (0.42) ALDH1A1TSHRTHRBTDP1
SCHEMBL735183 0.78 ALDH1A1 (0.41) ALDH1A1TSHRTHRBTDP1KDM4E
Chloromethane SCHEMBL253218 0.77 ALDH1A1 (0.39) ALDH1A1TSHRTHRBTDP1KDM4E
SCHEMBL9578354 0.76 ALDH1A1 (0.42) ALDH1A1TSHRTHRBTDP1
Hydrochloric Acid SCHEMBL7877860 0.75 ALDH1A1 (0.38) ALDH1A1TSHRTHRBTDP1
Hydrochloric Acid SCHEMBL327263 0.75 ALDH1A1 (0.38) ALDH1A1TSHRTHRBTDP1
SCHEMBL3817861 0.75 ALDH1A1 (0.38) ALDH1A1TSHRTHRBTDP1
SCHEMBL7954579 0.75 TSHR (0.44) ALDH1A1TSHRTHRBTDP1
SCHEMBL1401750 0.75 ALDH1A1 (0.46) ALDH1A1TSHRTHRBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221761-A1 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM NOVARTIS AG (CH) 2009-09-03 US claimed
EP-2072541-A2 Process for removing residual volatile monomers from a polymer in powder form Novartis Ag (CH) 2009-06-24 EP claimed
US-20080306233-A1 Process for Removing Residual Volatile Monomers from a Polymer in Powder form NOVARTIS AG (CH) 2008-12-11 US claimed
EP-1966252-A2 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM Novartis AG (CH) 2008-09-10 EP claimed
WO-2007071356-A2 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM NOVARTIS AG (CH) 2007-06-28 WO claimed
WO-2024119303-A1 MODIFIED HOT-MELT PRESSURE SENSITIVE ADHESIVE FOR CHINESE HERBAL MEDICINE PATCHES, AND PATCHES MADE THEREBY HENKEL AG & CO. KGAA (DE) 2024-06-13 WO disclosed
US-20090221761-A1 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM NOVARTIS AG (CH) 2009-09-03 US disclosed
EP-2072541-A2 Process for removing residual volatile monomers from a polymer in powder form Novartis Ag (CH) 2009-06-24 EP disclosed
US-20080306233-A1 Process for Removing Residual Volatile Monomers from a Polymer in Powder form NOVARTIS AG (CH) 2008-12-11 US disclosed
EP-1966252-A2 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM Novartis AG (CH) 2008-09-10 EP disclosed
WO-2007071356-A2 PROCESS FOR REMOVING RESIDUAL VOLATILE MONOMERS FROM A POLYMER IN POWDER FORM NOVARTIS AG (CH) 2007-06-28 WO disclosed